Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.

Autor: Nabi O; Washington University in St Louis School of Medicine, Saint Louis, Missouri, USA.; Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France., Lapidus N; Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France., Boursier J; Hepatogastroenterology Department, Anger University Hospital, Angers, France.; HIFIH Laboratory, UPRES EA3859, SFR 4208, Angers University, Angers, France., de Ledinghen V; Bordeaux University Hospital Branch, Bordeaux, France., Petit JM; Department of Endocrinology-Diabetology, Dijon University Hospital, Dijon, France., Kab S; Versailles-Saint Quentin University, UMS 11 Inserm, France., Renuy A; Versailles-Saint Quentin University, UMS 11 Inserm, France., Zins M; Versailles-Saint Quentin University, UMS 11 Inserm, France.; Université de Paris, Paris, France., Lacombe K; Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France.; Infectious Diseases Department, Hôpital Saint-Antoine, AP-HP, Paris, France., Serfaty L; Hepatogastroenterology Service, Hôpital Hautepierre, Strasbourg University Hospital, France.; Sorbonne University, Inserm UMR_S938, Paris, France.
Jazyk: angličtina
Zdroj: Hepatology (Baltimore, Md.) [Hepatology] 2024 May 01; Vol. 79 (5), pp. E130-E131. Date of Electronic Publication: 2024 Jan 22.
DOI: 10.1097/HEP.0000000000000755
Databáze: MEDLINE